The recent COVID-19 pandemic has spurred innovations throughout the bioscience and medical device community. From emerging antibody testing methods to new ventilator technology, companies throughout the country are rapidly developing new inventions in response to this public health threat.

The U.S. Patent Office is offering programs to further incentivize innovation and fast track patent examinations that will help innovators protect their technologies. Find out how to take advantage of these changes at the Virtual BioBreakfast: Prioritized Patent Examination for COVID-19 Technologies.

Register by June 29 at 4:00 pm MDT to receive the Zoom link information.

Registration is complimentary to all CBSA members. Registration is $25 for non-members. 

Speakers:
Gary J. Connell, Shareholder, Sheridan Ross
Rita P. Sanzgiri, Ph. D., Shareholder, Sheridan Ross

Event Sponsor:

Sustaining Sponsor: